Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03732703
Title Myeloma-Developing Regimens Using Genomics (MyDRUG) (MyDRUG)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Multiple Myeloma Research Consortium
Indications

multiple myeloma

Therapies

Dexamethasone + Enasidenib + Ixazomib + Pomalidomide

Cobimetinib + Dexamethasone + Ixazomib + Pomalidomide

Dexamethasone + Erdafitinib + Ixazomib + Pomalidomide

Dexamethasone + Ixazomib + Pomalidomide + Venetoclax

Abemaciclib + Dexamethasone + Ixazomib + Pomalidomide

Daratumumab + Dexamethasone + Ixazomib + Pomalidomide

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST